keyword
https://read.qxmd.com/read/38656217/doxycycline-as-postsexual-exposure-prophylaxis-use-acceptability-and-associated-sexual-health-behaviors-among-a-multi-site-sample-of-clinical-trial-participants
#1
MULTICENTER STUDY
Rob J Fredericksen, Rodney Perkins, Clare E Brown, Chase Cannon, Carolina Lopez, Alison Cohee, Julia Cook Dombrowski, Stephanie Cohen, Cheryl Malinski, Minh Powell, Anne F Luetkemeyer, Connie Celum, Katerina Christopoulos
Doxycycline postexposure prophylaxis (doxy-PEP) reduces sexually transmitted infections (STIs) in men who have sex with men (MSM) and transgender women (TGW). In a clinical trial of doxy-PEP, we sought to assess acceptability, impact, and meaning of doxy-PEP use among MSM/TGW. We conducted semistructured, in-depth 1:1 interviews with MSM and TGW enrolled in the intervention arm of the Doxy-PEP study. We queried motivations for and meaning of use, attitudes, beliefs, adherence, effect on sexual behaviors, and partner, community, and structural factors related to use...
April 2024: AIDS Patient Care and STDs
https://read.qxmd.com/read/38656214/perspectives-on-injectable-hiv-pre-exposure-prophylaxis-a-qualitative-study-of-health-care-providers-in-the-united-states
#2
JOURNAL ARTICLE
Jacob Bleasdale, Meghan McCole, Kenneth Cole, Amy Hequembourg, Gene D Morse, Sarahmona M Przybyla
The introduction of injectable HIV pre-exposure prophylaxis (PrEP) has the potential to significantly change the biomedical HIV prevention landscape. However, effective implementation will require health care providers to adopt, prescribe, and administer injectable PrEP within clinical settings. This study qualitatively examined challenges and benefit of injectable PrEP implementation from the perspective of health care providers. From April to August 2022, we conducted 19 in-depth interviews with current PrEP-prescribing health care providers in New York State, including 3 physician assistants, 5 physicians, and 11 nurse practitioners...
April 2024: AIDS Patient Care and STDs
https://read.qxmd.com/read/38651127/utilization-of-post-exposure-prophylaxis-potentially-contributed-to-the-changes-of-risk-behaviors-among-men-who-have-sex-with-men-in-china
#3
JOURNAL ARTICLE
Rong Su, Yi Liu, Peilong Li, Lin Ge, Meizhen Liao, Yong Fu, Xin Song, Houlin Tang, Dongmin Li
BACKGROUND: The HIV infection status among men who have sex with men (MSM) in China is a cause for concern. Post-exposure prophylaxis (PEP) serves as a highly effective biomedical preventive measure against HIV infection. Substantial evidence has established an association between PEP utilization and risk behaviors among MSM, but whether the utilization of PEP has an impact on risk behaviors remains unknown. This study sought to elucidate the impact of PEP usage on risk behaviors among MSM and provide recommendations for developing targeted HIV prevention programs...
2024: Frontiers in Public Health
https://read.qxmd.com/read/38648372/pre-exposure-prophylaxis-and-telemedicine-during-coronavirus-covid-19-a-qualitative-study-of-the-experiences-of-health-care-professionals-in-mexico
#4
JOURNAL ARTICLE
A Cruz-Bañares, A Rojas-Carmona, S Aguilera-Mijares, A Martínez-Dávalos, S Bautista-Arredondo, H Vermandere
Background Telemedicine, which involves utilising technologies for remote health care delivery, proved useful to continue offering certain health services during the coronavirus disease 2019 (COVID-19) lockdown. However, the extent of its effectiveness in delivering pre-exposure prophylaxis services for HIV prevention remains underexplored from the viewpoint of health care providers. Therefore, this study aimed to assess the experiences of health care professionals in Mexico who utilised telemedicine for delivering pre-exposure prophylaxis services during the COVID-19 contingency...
April 2024: Sexual Health
https://read.qxmd.com/read/38626958/multicentre-double-blind-randomised-placebo-controlled-trial-evaluating-the-efficacy-of-the-meningococcal-b-vaccine-4cmenb-bexsero-against-neisseria-gonorrhoeae-infection-in-men-who-have-sex-with-men-the-gogovax-study-protocol
#5
JOURNAL ARTICLE
Kate L Seib, Basil Donovan, Caroline Thng, David A Lewis, Anna McNulty, Christopher K Fairley, Barbara Yeung, Fengyi Jin, Doug Fraser, Benjamin R Bavinton, Matthew Law, Marcus Y Chen, Eric P F Chow, David M Whiley, Brent Mackie, Michael P Jennings, Amy V Jennison, Monica M Lahra, Andrew E Grulich
INTRODUCTION: Gonorrhoea, the sexually transmissible infection caused by Neisseria gonorrhoeae , has a substantial impact on sexual and reproductive health globally with an estimated 82 million new infections each year worldwide. N. gonorrhoeae antimicrobial resistance continues to escalate, and disease control is largely reliant on effective therapy as there is no proven effective gonococcal vaccine available. However, there is increasing evidence from observational cohort studies that the serogroup B meningococcal vaccine four-component meningitis B vaccine (4CMenB) (Bexsero), licensed to prevent invasive disease caused by Neisseria meningitidis , may provide cross-protection against the closely related bacterium N...
April 16, 2024: BMJ Open
https://read.qxmd.com/read/38621237/clinical-decision-support-system-for-guidelines-based-treatment-of-gonococcal-infections-screening-for-hiv-and-prescription-of-pre-exposure-prophylaxis-design-and-implementation-study
#6
JOURNAL ARTICLE
Saugat Karki, Sarah Shaw, Michael Lieberman, Alejandro Pérez, Jonathan Pincus, Priya Jakhmola, Amrita Tailor, Oyinkansola Bukky Ogunrinde, Danielle Sill, Shane Morgan, Miguel Alvarez, Jonathan Todd, Dawn Smith, Ninad Mishra
BACKGROUND: The syndemic nature of gonococcal infections and HIV provides an opportunity to develop a synergistic intervention tool that could address the need for adequate treatment for gonorrhea, screen for HIV infections, and offer pre-exposure prophylaxis (PrEP) for persons who meet the criteria. By leveraging information available on electronic health records, a clinical decision support (CDS) system tool could fulfill this need and improve adherence to Centers for Disease Control and Prevention (CDC) treatment and screening guidelines for gonorrhea, HIV, and PrEP...
April 15, 2024: JMIR Formative Research
https://read.qxmd.com/read/38604993/understanding-effective-post-test-linkage-strategies-for-hiv-prevention-and-care-a-scoping-review
#7
REVIEW
Beatrice Wamuti, Muhammad S Jamil, Nandi Siegfried, Nathan Ford, Rachel Baggaley, Cheryl Case Johnson, Peter Cherutich
INTRODUCTION: Following HIV testing services (HTS), the World Health Organization recommends prompt linkage to prevention and treatment. Scale-up of effective linkage strategies is essential to achieving the global 95-95-95 goals for maintaining low HIV incidence by 2030 and reducing HIV-related morbidity and mortality. Whereas linkage to care including same-day antiretroviral therapy (ART) initiation for all people with HIV is now routinely implemented in testing programmes, linkage to HIV prevention interventions including behavioural or biomedical strategies, for HIV-negative individuals remains sub-optimal...
April 2024: Journal of the International AIDS Society
https://read.qxmd.com/read/38603545/management-of-acute-sexual-assault-presenting-to-a-large-australian-sexual-health-clinic-in-2012-2021-a-retrospective-clinical-audit
#8
JOURNAL ARTICLE
Aleah Kink, Janet M Towns, Christopher K Fairley, Tiffany R Phillips, Catriona S Bradshaw, Eric P F Chow
Background The incidence of sexual assault continues to rise in Australia. This study aimed to describe the nature of assault, HIV/STI positivity, and its management at a sexual health clinic. Methods We performed a chart review of 516 sexual assault cases presenting to Melbourne Sexual Health Centre between 2012 and 2021, collecting data on victim demographics, details of assault, HIV/STI testing and positivity, police involvement, and offer of counselling. Results We included 516 cases: 124 males (24.0%); 384 females (74...
April 2024: Sexual Health
https://read.qxmd.com/read/38599462/experiences-of-the-national-post-exposure-prophylaxis-hotline-pepline-occupational-pep-consultation-needs-and-trends-2014-2022
#9
JOURNAL ARTICLE
Nakayoshi April, Gruta Cristina, R Lutes Erin, Stupar Lauren, Goldhammer Brenda, Bositis Christopher, Chu Carolyn
BACKGROUND: The National Clinician Consultation Center (NCCC) operates the PEPline, a federally-funded educational resource providing bloodborne pathogen exposure management tele-consultation to U.S. clinicians. METHODS: 67,109 occupational post-exposure prophylaxis (PEP) consultations (January 2014 to December 2022) were retrospectively analyzed to describe PEPline utilization and common inquiries addressed by NCCC consultants. RESULTS: Most calls involved percutaneous incidents (70%); blood was the most common body fluid discussed (60%)...
April 8, 2024: American Journal of Infection Control
https://read.qxmd.com/read/38593613/the-gender-of-prep-transgender-men-negotiating-legitimacy-in-france
#10
JOURNAL ARTICLE
Clark Pignedoli, Paul Rivest
Transmasculine people (TM) constitute an invisibilized group within the transgender population. Little is known about their relationship to sexuality in transgender medicine. Their presence and needs are still unacknowledged within HIV prevention research and services. Pre-exposure prophylaxis (or PrEP) is an oral medication that prevents HIV in HIV-negative individuals at risk of infection with the virus. This paper proposes to bring TM back into the focus of PrEP research by questioning how they navigate and situate themselves in relation to existing PrEP categorization and services, and how they think about and (re)shape the meanings of PrEP...
March 31, 2024: Social Science & Medicine
https://read.qxmd.com/read/38590462/awareness-perception-and-practice-regarding-needle-stick-injury-and-its-prevention-among-healthcare-workers-in-a-tertiary-care-hospital-in-southern-india
#11
JOURNAL ARTICLE
D Anandadurai, R Praisie, Sriandaal Venkateshvaran, Sudhir B Nelson, Manoje Thulasiram
Background Needle stick injuries caused by various sharp and other items like hypodermic needles and intravenous cannulas are important occupational hazards for healthcare workers (HCW). Preventing injuries is the most effective way to protect workers and requires good awareness and perceptions associated with practice on a daily basis. Therefore, we did a descriptive cross-sectional study involving healthcare workers in a tertiary care hospital to find the level of awareness, perception, and practice associated with needle stick injury and its prevention...
March 2024: Curēus
https://read.qxmd.com/read/38575314/in-the-fight-against-hiv-aids-the-arduous-implementation-of-government-funded-pre-exposure-prophylaxis-programme-in-taiwan
#12
JOURNAL ARTICLE
Hsun Yin Huang, Jyun Rong Huang, Pei Chun Chan, Chia Chi Lee
INTRODUCTION: The government-funded pre-exposure prophylaxis (PrEP) programme was targeted to those aged under 30 years or serodiscordant couples and implemented in September 2018-October 2020 in Taiwan. The study aimed to examine the effectiveness of the programme and the relationship between sexually transmitted disease (STD) and HIV seroconversion. METHODS: This study was a retrospective cohort analysis with questionnaires designed for participants who joined the aforementioned programme in the PrEP-designated hospitals...
April 4, 2024: Sexually Transmitted Infections
https://read.qxmd.com/read/38574992/pre-exposure-and-post-exposure-prophylaxis-access-in-rural-versus-urban-pharmacies-in-georgia-and-pennsylvania
#13
JOURNAL ARTICLE
Yasaswi Kislovskiy, Natalie Pino, Natalie D Crawford, Tierney Woitas, Shannon Cason, Anushka Konka, Tierra Kimble, Iris Olson, Dan Villarreal, Marian Jarlenski
BACKGROUND: Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) prevent HIV among individuals at high risk for acquisition. Pre-existing structural barriers to PrEP/PEP access among rural patients may be exacerbated further if pharmacies do not keep PrEP/PEP in stock, constituting a significant barrier to mitigating the HIV epidemic. OBJECTIVES: To compare PrEP/PEP availability for same-day pickup in rural vs urban Georgia and Pennsylvania pharmacies...
April 2, 2024: Journal of the American Pharmacists Association: JAPhA
https://read.qxmd.com/read/38551313/uptake-and-challenges-with-daily-oral-pre-exposure-prophylaxis-among-men-who-have-sex-with-men-and-transgender-women-suburban-yangon-myanmar
#14
JOURNAL ARTICLE
Ni Ni Tun, Frank Smithuis, Nyan Lynn Tun, Myo Min Min Hteik, Myat Ko Ko, Lutgarde Lynen, Tom Decroo, Eric Florence, Tinne Gils
BACKGROUND: Pre-exposure prophylaxis (PrEP) is effective for human immunodeficiency virus (HIV) prevention in risk groups. We assessed PrEP uptake and 12-month retention among men who have sex with men (MSM) and transgender women (TGW) in Myanmar during the coronavirus disease 2019 pandemic and a political crisis. METHODS: Using prospectively collected data, we assessed the proportion of persons eligible, initiated and retained 12 months on PrEP. We calculated HIV and syphilis incidence among those initiated on PrEP...
March 29, 2024: International Health
https://read.qxmd.com/read/38543242/preclinical-and-early-clinical-development-of-tenofovir-alafenamide-elvitegravir-topical-inserts-for-effective-on-demand-vaginal-and-rectal-hiv-prevention
#15
JOURNAL ARTICLE
M Melissa Peet, Vivek Agrahari, Meredith R Clark, Gustavo F Doncel
HIV/AIDS remains a global public health issue, and products available for the prevention of HIV infections are limited, especially those for short-acting, on-demand, user-controlled applications. Topical inserts are products that can be applied vaginally or rectally and have been explored as drug delivery systems. To fill the gap in the HIV prevention product pipeline, CONRAD has developed a topical insert containing tenofovir alafenamide fumarate (TAF) and elvitegravir (EVG), two potent and synergistic antiretrovirals, as a simple, low-cost, and discreet option that can be self-administered vaginally and/or rectally, before and after coitus...
March 1, 2024: Pharmaceutics
https://read.qxmd.com/read/38522118/men-after-the-sexual-assault-the-journey-from-medical-service-to-court
#16
JOURNAL ARTICLE
Vanita R Parekh, Janine McMinn, Anna Brkic, Ash Byron, Katelyn Pomroy, Mick Woodburn
BACKGROUND: There may be significant physical and psychological consequences and impacts for males who experience sexual assault as adults, however, published literature in this context is sparse, specifically for the investigative outcomes in the criminal legal process. METHOD: This clinical audit tracked 138 adult males who presented for forensic and medical sexual assault care from initial presentation to ACT Police investigation and court outcome from 2004 to 2022...
March 19, 2024: Journal of Forensic and Legal Medicine
https://read.qxmd.com/read/38508708/impact-of-national-commissioning-of-pre-exposure-prophylaxis-prep-on-equity-of-access-in-england-a-prep-to-need-ratio-investigation
#17
JOURNAL ARTICLE
Flavien Coukan, Ann Sullivan, Holly Mitchell, Sajjida Jaffer, Andy Williams, John Saunders, Christina Atchison, Helen Ward
OBJECTIVES: HIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV acquisition. In England, NHS availability was limited to participants of the PrEP Impact Trial until late 2020. Some key populations at greater risk of HIV were under-represented in the trial suggesting inequities in trial PrEP access. We used the PrEP-to-need ratio (PnR; number of PrEP users divided by new HIV diagnoses) to investigate whether PrEP access improved following routine commissioning in October 2020 and identify populations most underserved by PrEP...
March 20, 2024: Sexually Transmitted Infections
https://read.qxmd.com/read/38492264/-to-do-so-in-a-patient-centred-way-is-not-particularly-lucrative-the-effects-of-neoliberal-health-care-on-prep-implementation-and-delivery
#18
JOURNAL ARTICLE
Jad Sinno, Emerich Daroya, Alex Wells, Mark Hull, Nathan J Lachowsky, Darrell H S Tan, Daniel Grace
BACKGROUND: HIV pre-exposure prophylaxis (PrEP) is a highly effective biomedical intervention used by HIV-negative people to prevent HIV acquisition. Despite increased use of PrEP worldwide, several barriers to PrEP implementation have resulted in insufficient uptake, inadequate adherence, and frequent discontinuation. Our objective was to interrogate the social, political, and economic conditions shaping PrEP implementation and delivery among gay, bisexual, queer and other men who have sex with men (GBQM) in Ontario, Canada...
March 4, 2024: Social Science & Medicine
https://read.qxmd.com/read/38479437/australian-consensus-statement-on-doxycycline-post-exposure-prophylaxis-doxy-pep-for-the-prevention-of-syphilis-chlamydia-and-gonorrhoea-among-gay-bisexual-and-other-men-who-have-sex-with-men
#19
JOURNAL ARTICLE
Vincent J Cornelisse, Benjamin Riley, Nicholas A Medland
INTRODUCTION: Doxycycline post-exposure prophylaxis (doxy-PEP) involves consuming 200 mg of doxycycline up to 72 hours after a condomless sex act to reduce the risk of bacterial sexually transmitted infections (STIs). Recent clinical trials of doxy-PEP have demonstrated significant reductions in syphilis, chlamydia and, to a lesser degree, gonorrhoea among gay, bisexual and other men who have sex with men (GBMSM). There is a high level of interest in doxy-PEP in the GBMSM community and, in response, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) held a national consensus conference with the aim of creating preliminary guidance for clinicians, community, researchers and policy makers...
March 13, 2024: Medical Journal of Australia
https://read.qxmd.com/read/38471990/mitoquinone-mesylate-as-post-exposure-prophylaxis-against-sars-cov-2-infection-in-humans-an-exploratory-single-center-pragmatic-open-label-non-randomized-pilot-clinical-trial-with-matched-controls
#20
JOURNAL ARTICLE
Keren Chen, Nicholas J Jackson, Theodoros Kelesidis
BACKGROUND: An ongoing important need exists to rapidly develop novel therapeutics for COVID-19 that will retain antiviral efficacy in the setting of rapidly evolving SARS-CoV-2 variants and potential future development of resistance of SARS-COV-2 to remdesivir and protease inhibitors. To date, there is no FDA-approved treatment for post-exposure prophylaxis against SAR-CoV-2. We have shown that the mitochondrial antioxidant mitoquinone/mitoquinol mesylate (Mito-MES), a dietary supplement, has antiviral activity against SARS-CoV-2 in vitro and in SARS-CoV-2 infected K18-hACE2 mice...
March 7, 2024: EBioMedicine
keyword
keyword
52998
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.